Doping- and photo-induced absorptions are studied in the chapter on the basis of the absorption spectra of model compounds: the radical ions, the divalent ions, and the anions of various oligomers.
We use 1-R-T to calculate the absorption of the model, where R and T represent reflectivity and transmissivity, respectively.
This comparative study evaluated the effect of several experimental variables on the absorption of six model [14C]-labeled compounds (caffeine, cortisone, diclofenac sodium, mannitol, salicylic acid, and testosterone) through porcine skin.
Their promoting activity on the percutaneous absorption of five model drugs, 5-fluorouracil (5-FU), isosorbide dinitrate (ISDN), lidocaine (LD), ketoprofen (KP), indomethacin (IM), which were selected based on their lipophilicity represented by log KO/W, was tested in vitro across full thickness rat skin with each of the evaluated drugs in saturated donor solution.
Indeed, both CS-coated systems (nanocapsules and CS-coated nanoparticles) showed an important capacity to enhance the intestinal absorption of the model peptide, salmon calcitonin, as shown by the important and long-lasting decrease in the calcemia levels observed in rats.
Structures and X-ray absorption spectra of model compounds as well as X-ray diffraction patterns of the biochars.
The results of acoustic absorption modeling of porous concrete considering the gradation and shape of aggregates and void ratio are presented.
The human peptide transporter, hPepT1, situated in the small intestine, may be exploited to increase absorption of drugs or model drugs by attaching them to a dipeptide, which is recognised by hPepT1.
For oral administration, which is more complex, a number of absorption models have been described in the literature.
The model features a detailed representation of absorption models for oral glucose, subcutaneous insulin and glucagon, and an insulin receptor model relating pharmacokinetic properties to pharmacodynamic effects.
